Contact Us
  Search
The Business Research Company Logo
Global Enteral Stents Market Report 2026
Published :January 2026
Pages :150
Format :PDF
Delivery Time :2-3 Business Days
Why 2-3 days? We update the report with the latest data and news before delivery. Let us know if you need us to expedite.
Report Price :$4,490.00

Enteral Stents Market Report 2026

Global Outlook – By Stent Type (Esophageal Stents, Gastroduodenal Stents, Colon Stents), By Material Type (Self-Expandable Plastic Stents, Self-Expandable Metal Stents), By End User (Hospitals, Specialty Clinics, Ambulatory Centers, Research Centers) - Market Size, Trends, And Global Forecast 2026-2035

Enteral Stents Market Overview

• Enteral Stents market size has reached to $1.55 billion in 2025 • Expected to grow to $2.22 billion in 2030 at a compound annual growth rate (CAGR) of 7.4% • Growth Driver: Rising Gastrointestinal Disorders Fuel Growth In The Market • North America was the largest region in 2025.
Research Expert

Book your 30 minutes free consultation with our research experts

What Is Covered Under Enteral Stents Market?

Enteral stents are medical devices inserted into the digestive tract to relieve blockages or narrowing, typically caused by tumors or other gastrointestinal issues. These stents help maintain an open passage for food or waste, providing temporary or long-term relief for patients with conditions such as cancer or crohn's disease. The main types of enteral stents are esophageal stents, gastroduodenal stents, and colon stents. Esophageal stents are medical devices specifically designed to keep the esophagus open, allowing food and liquids to pass through. It is made up of various materials, such as self-expandable plastic stents and self-expandable metal stents, and caters to various end users, including hospitals, specialty clinics, ambulatory centers, and research centers.
Enteral Stents Market Global Report 2026 Market Report bar graph

What Is The Enteral Stents Market Size and Share 2026?

The enteral stents market size has grown strongly in recent years. It will grow from $1.55 billion in 2025 to $1.67 billion in 2026 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to gastrointestinal cancer prevalence, bowel obstruction cases, adoption of endoscopic procedures, hospital GI infrastructure growth, palliative care demand.

What Is The Enteral Stents Market Growth Forecast?

The enteral stents market size is expected to see strong growth in the next few years. It will grow to $2.22 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to aging population growth, minimally invasive surgery adoption, biodegradable stent development, oncology treatment expansion, advanced GI care access. Major trends in the forecast period include rising demand for minimally invasive GI procedures, increased use of palliative cancer care devices, growth in self-expandable metal stents, expansion of gastrointestinal oncology treatments, focus on long-term luminal patency.

Global Enteral Stents Market Segmentation

1) By Stent Type: Esophageal Stents, Gastroduodenal Stents, Colon Stents 2) By Material Type: Self-Expandable Plastic Stents, Self-Expandable Metal Stents 3) By End User: Hospitals, Specialty Clinics, Ambulatory Centers, Research Centers Subsegments: 1) By Esophageal Stents: Self-Expanding Metal Esophageal Stents, Covered Esophageal Stents, Uncovered Esophageal Stents, Hybrid Esophageal Stents, Temporary Esophageal Stents 2) By Gastroduodenal Stents: Self-Expanding Metal Gastroduodenal Stents, Covered Gastroduodenal Stents, Uncovered Gastroduodenal Stents, Biodegradable Gastroduodenal Stents 3) By Colon Stents: Self-Expanding Metal Colon Stents, Covered Colon Stents, Uncovered Colon Stents, Biodegradable Colon Stents, Colon Stents For Colonic Obstruction

What Are The Drivers Of The Enteral Stents Market?

The increasing prevalence of gastrointestinal disorders is expected to propel the growth of the enteral stents market going forward. Gastrointestinal disorders refer to a wide range of conditions affecting the gastrointestinal tract, including the esophagus, stomach, intestines, and accessory organs, leading to symptoms such as pain and discomfort. The increasing prevalence of gastrointestinal disorders is due to poor dietary habits, rising stress levels, sedentary lifestyles, increased use of antibiotics, and growing exposure to environmental toxins. Enteral stents are essential in managing gastrointestinal disorders by offering a minimally invasive solution to relieve obstructions, restore the natural flow of food and fluids, and improve overall digestive function, thereby enhancing patient comfort and quality of life. For instance, in June 2023, according to Crohn’s and Colitis Canada, a Canada-based nonprofit organization, in 2023, an estimated 322,600 Canadians, accounting for 0.8% of the population, were living with IBD. Projections indicate this figure could rise to 470,000, or 1.1% of the population, by 2035. Therefore, the increasing prevalence of gastrointestinal disorders is driving the growth of the enteral stent industry. The rising prevalence of cancer is expected to propel the growth of the enteral stents market going forward. Cancer refers to a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. The rising prevalence of cancer is driven by an aging population, lifestyle factors, improved diagnostic methods, genetic predisposition, and better healthcare access and awareness. Enteral stents are used to relieve gastrointestinal obstructions caused by cancer, improving symptoms such as dysphagia and preserving nutrient intake. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, by 2050, over 35 million new cancer cases are projected, marking a 77% increase from the estimated 20 million cases in 2022. Therefore, the rising prevalence of cancer is driving the growth of the enteral stents industry.

Key Players In The Global Enteral Stents Market

Major companies operating in the enteral stents market are Cardinal Health Inc., Medtronic Inc., Boston Scientific Corporation, Olympus Corporation, Lepu Medical Technology (Beijing) Co Ltd., Endo‑Therapeutics Inc., Cook Medical, Micro‑Tech (Nanjing) Co Ltd., Merit Medical Systems Inc., ConMed Corporation, Medi‑Globe GmbH, Taewoong Medical Inc., ELLA‑CS s.r.o., S&G Biotech Inc., Nanwei Medical Technology Co Ltd, M I Tech Co Ltd, ACE Medical Devices Pvt Ltd, Allium Ltd, ENDOCOR GmbH & Co KG, Sewoon Medical Co Ltd, Changzhou Health Microport Medical Device Co Ltd, Medorah Meditek Pvt Ltd, Advin Health Care, ENDO‑FLEX GmbH, CITEC, QualiMed, W L Gore & Associates Inc., Becton Dickinson and Company

What Are Latest Mergers And Acquisitions In The Enteral Stents Market?

In February 2023, Olympus Corporation, a Japan-based manufacturer of optics and reprography products, acquired Taewoong Medical Co., Ltd. for $370 million. Through this acquisition, Olympus aims to strengthen Olympus' gastrointestinal (GI) endotherapy offerings by integrating Taewoong's innovative technologies and product portfolio, which includes metallic stents used in various GI procedures. Taewoong Medical Co., Ltd., a South Korea-based manufacturer of medical equipment, offers enteral stents.

Regional Outlook

North America was the largest region in the enteral stents market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Need data on a specific region in this market?

What Defines the Enteral Stents Market?

The enteral stent market consists of sales of metal stents, plastic stents, covered stents, self-expanding stents, and biliary stents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Enteral Stents Market Report 2026?

The enteral stents market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the enteral stents industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Enteral Stents Market Report Forecast Analysis

Report Attribute Details
Market Size Value In 2026$1.67 billion
Revenue Forecast In 2035$2.22 billion
Growth RateCAGR of 7.7% from 2026 to 2035
Base Year For Estimation2025
Actual Estimates/Historical Data2020-2025
Forecast Period2026 - 2030 - 2035
Market RepresentationRevenue in USD Billion and CAGR from 2026 to 2035
Segments CoveredStent Type, Material Type, End User
Regional ScopeAsia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country ScopeThe countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies ProfiledCardinal Health Inc., Medtronic Inc., Boston Scientific Corporation, Olympus Corporation, Lepu Medical Technology (Beijing) Co Ltd., Endo‑Therapeutics Inc., Cook Medical, Micro‑Tech (Nanjing) Co Ltd., Merit Medical Systems Inc., ConMed Corporation, Medi‑Globe GmbH, Taewoong Medical Inc., ELLA‑CS s.r.o., S&G Biotech Inc., Nanwei Medical Technology Co Ltd, M I Tech Co Ltd, ACE Medical Devices Pvt Ltd, Allium Ltd, ENDOCOR GmbH & Co KG, Sewoon Medical Co Ltd, Changzhou Health Microport Medical Device Co Ltd, Medorah Meditek Pvt Ltd, Advin Health Care, ENDO‑FLEX GmbH, CITEC, QualiMed, W L Gore & Associates Inc., Becton Dickinson and Company
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options
Chat with us